ACRS vs BCAX: stock comparison and AI forecast
Aclaris Therapeutics, Inc. (ACRS) and Bicara Therapeutics Inc. (BCAX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACRS Aclaris Therapeutics, Inc.
- Market Cap
- $531M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
BCAX Bicara Therapeutics Inc.
- Price
- $8.19 -64.5% · 6M
- Market Cap
- $542M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ACRS and BCAX have similar market capitalizations ($531M and $542M).
- ACRS carries 0.30 times debt per unit of equity, against 0.09 times for BCAX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACRS | BCAX |
|---|---|---|
| Market Cap | $531M | $542M |
| P/B Ratio | 3.19x | 1.16x |
| EPS | $-0.53 | $-2.84 |
| Book Value/Share | $1.13 | $7.08 |
| Revenue/Share | $0.04 | – |
| FCF/Share | $-0.51 | $-2.04 |
Profitability & Margins
| Metric | ACRS | BCAX |
|---|---|---|
| ROE | -47.7% | -39.5% |
| ROA | -36.8% | -36.2% |
| ROIC | -47.2% | -43.1% |
| Operating Margin | -1414.0% | – |
| Net Margin | -1244.1% | – |
| EBT Margin | -1368.0% | – |
| Tax Rate | – | -0.1% |
Financial Health
| Metric | ACRS | BCAX |
|---|---|---|
| Current Ratio | 5.09x | 11.59x |
| D/E Ratio | 0.30x | 0.09x |
| Financial Leverage | 1.30x | 1.09x |
| Interest Coverage | -665.0x | – |
| Working Capital | $99M | $460M |
Cash Flow
| Metric | ACRS | BCAX |
|---|---|---|
| Operating Cash Flow | -$75M | -$135M |
| Free Cash Flow | -$75M | -$135M |
| Capital Spending | -$110K | -$400K |
| FCF/Sales | -1176.6% | – |
| CapEx/Sales | 1.7% | – |
Operational Efficiency
| Metric | ACRS | BCAX |
|---|---|---|
| Asset Turnover | 0.03x | – |
| Fixed Assets Turnover | 10.3x | – |
| Payables Period | 2482 days | – |
Income Statement
| Metric | ACRS | BCAX |
|---|---|---|
| Total Revenue | $6M | – |
| Operating Income | -$91M | -$202M |
| Net Income | -$80M | -$185M |
| R&D Expense | $66M | $140M |
| Cost of Goods Sold | $1M | – |
Dividend & Shareholder Information
| Metric | ACRS | BCAX |
|---|---|---|
| Shares Outstanding | 147M | 66M |
ACRS vs BCAX: stock comparison and AI forecast
Which is bigger, ACRS or BCAX?
ACRS and BCAX have similar market capitalizations ($531M and $542M).
Which one does Intratio's AI model rank higher, ACRS or BCAX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.